Part of the ICU Emergencies Hub — browse every related guide in one place.
The QTc is one of the few numbers on the monitor that lets a nurse prevent an arrest rather than respond to one. Every ICU stocks a long list of QT-prolonging drugs, half the patients have shifting electrolytes, and torsades is the price of not paying attention to how those factors add up. The skill here is boring and lifesaving: know what the QTc is, know what pushes it up, and act on the trend before the rhythm strip forces you to.
The QT interval runs from the start of the QRS complex to the end of the T wave — the total time the ventricles spend depolarizing and repolarizing. Because the QT naturally shortens as heart rate rises, a raw QT is meaningless without correcting for rate, which gives the QTc. Most monitors and 12-lead machines display an automated QTc, but that automated number is only a starting point: it can be thrown off by a wandering T-wave endpoint, prominent U waves, wide QRS, and irregular rhythms like atrial fibrillation. When the QTc looks alarming, a manual measurement on a clean lead (often lead II or V5), measuring several beats and taking the longest reliable value, is the responsible confirmation.
The two thresholds worth memorizing are that a QTc over 500 ms marks substantially elevated torsades risk, and that a rise of more than 60 ms above the patient's own baseline is significant even if the absolute number still looks acceptable. A wide QRS (as in a bundle branch block or paced rhythm) inflates the QT mechanically; in those patients the trend and the specialist read matter more than the raw number.
Acquired long QT is almost always additive — several modest risk factors piling up rather than one dramatic cause. The big categories:
| Risk factor | Why it matters |
|---|---|
| QT-prolonging drugs | Antiarrhythmics (amiodarone, sotalol), many antipsychotics (haloperidol, quetiapine), methadone, ondansetron and other antiemetics, macrolide and fluoroquinolone antibiotics, some antifungals — and combinations multiply the effect |
| Hypokalemia | Low potassium directly prolongs repolarization — the single most common correctable driver |
| Hypomagnesemia | Low magnesium both prolongs QT and is the treatment for torsades — a double reason to keep it replete |
| Hypocalcemia | Lengthens the QT via the ST segment |
| Bradycardia | Slow rates lengthen the QT and create pause-dependent torsades |
| Female sex, older age, structural heart disease, hepatic/renal impairment | Baseline modifiers that lower the threshold and slow drug clearance |
The clinical reality is that a patient on amiodarone who becomes hypokalemic during diuresis, gets an antiemetic for nausea, and slides into a slow junctional rhythm overnight has quietly assembled four risk factors. No single order looks wrong; the sum is dangerous. Catching that stack is exactly what QTc monitoring is for.
QTc monitoring only works if someone acts on it. The practical workflow: establish a baseline QTc before starting a known QT-prolonging drug, recheck at intervals appropriate to the drug and the patient (often after loading, after dose changes, and with any new QT-prolonging agent), and trend it against electrolytes rather than reading each value in isolation. When the QTc crosses into the danger zone or climbs sharply, the nurse's job is to raise it — to the prescriber, out loud, as a specific concern: "his QTc is 520 and he's on haloperidol and ondansetron with a potassium of 3.2." That sentence is often what triggers holding the culprit drug, repleting electrolytes, and reassessing.
Many institutions use a formal risk score (the Tisdale score is a widely cited example) to flag high-risk patients on admission; if yours does, it is a tool for deciding who needs closer QTc surveillance, not a substitute for watching the number.
As the QTc rises, the interventions escalate in a predictable order: correct electrolytes (potassium and magnesium first), stop or substitute the offending drug(s) in conversation with the team, avoid bradycardia and pauses, and increase monitoring intensity. If torsades actually occurs, the specific first-line treatment is IV magnesium sulfate even when the magnesium level is normal, because it stabilizes the myocardium in this rhythm. Sustained torsades that compromises the patient is treated as the shockable emergency it is — defibrillation, since the polymorphic, disorganized rhythm generally can't be synchronized. For recurrent pause-dependent torsades, increasing the heart rate — with isoproterenol or overdrive pacing — shortens the QT and suppresses it, which is why bradycardia is the enemy here.
Acquired long QT is the rare cardiac emergency you can see coming on the monitor and head off at the bedside. Measure the QTc properly (and manually when the machine looks wrong), know that over 500 ms or a 60-ms jump is a call-the-provider moment, keep potassium and magnesium at the top of the range, and recognize that risk stacks silently across ordinary orders. Torsades treated is a magnesium push and maybe a shock; torsades prevented is a nurse who watched the number and made the stop conversation happen first.
Related: Torsades de pointes | Brugada syndrome | Magnesium sulfate guide | Potassium replacement | Cardioversion vs. defibrillation
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.